EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort

• Main Authors: Qintao Ge (Author), Jiawei Li (Author), Junyue Tao (Author), Rui Gao (Author), Chen Jin (Author), Jun Zhou (Author), Meng Zhang (Author), Zongyao Hao (Author), Jialin Meng (Author), Chaozhao Liang (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

EPM2A encodes a dual specificity phosphatase and has been proven to be a potential biomarker in several cancers but has not been mentioned in prostate cancer (PCA). We investigated the prognostic and therapeutic value of EPM2A in PCA. The TCGA-PRAD cohort was collected to evaluate the differential e...